why choose us

First received: April 04, 2023

Clinical Trial: Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Relapsed and/or Refractory Multiple Myeloma

Study Type: INTERVENTIONAL


Official Title: Open Label, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of CT0594CP in Patients With Relapsed and/or Refractory Multiple Myeloma or Plasma Cell Leukemia

Brief Summary: This is an open-label, single arm study to evaluate the safety and tolerability of treatment with CT0594CP CAR-T Cells in patients with relapsed and/or refractory multiple myeloma or Plasma Cell Leukemia

Read more